Composition and method-of-use claims
Keep gene, protein and compound identifiers consistent across claim sets.
Biotech & pharmaceutical patents
Biotech patents need the same name for every sequence and dose
Biotech and pharmaceutical patents repeat gene names, protein identifiers and dosage terms across claims, examples and sequence descriptions. PatentLingo builds a full-document glossary for this vocabulary first, then translates with the same terms and guidance throughout.
- docx patent drafts
- Gene and dosage terms locked
- Free preview before payment
Where this fits in biotech and pharma work
Experimental examples and dosage sections
Dosage values, units and experimental terminology stay aligned across long examples.
Cross-border regulatory-adjacent filings
Get a consistent draft translation before specialist review for filing in another jurisdiction.
How a biotech draft is handled
Upload docx
Submit the patent draft as a Word file so sequences, identifiers and examples are read in full.
Build the biotech glossary
Gene names, protein identifiers, dosage units and process terms are fixed once for the whole document.
Translate with shared terms
Examples, claims and description reuse the same glossary and guidance through delivery.
Why this matters for biotech patents
One identifier per entity
Gene and protein identifiers are not rendered two different ways in the same draft.
Dosage and units preserved
Dosage values and units are kept as written, not reformatted or recalculated.
Example terminology reused
Experimental method terms stay consistent from one example to the next.
Assisted review available
In Assisted mode, review and edit the glossary before the full translation runs.
Biotech patent translation questions
Can it keep gene and protein names consistent?
Yes. A glossary is built from your draft before translation, and the same identifiers are reused across claims and examples.
Will dosage values and units be changed?
No. Numeric dosage values and units are kept as written; the workflow does not recalculate or reformat them.
Does this replace review by a biotech or pharma specialist?
No. It produces a reviewable draft. Technical and scientific accuracy should be confirmed by a subject-matter expert before filing.
What about sequence listings?
Only docx patent drafts are supported today; sequence-listing-specific handling is not a current feature.
How is pricing calculated?
Pricing is tiered by source character count and shown before you upload.
Keep every gene and dosage term aligned
Upload a docx biotech or pharmaceutical patent draft and preview a sample before the full translation.
Preview a biotech patent